LIPID LOWERING THERAPY USE IN SECONDARY PREVENTION: AN ANALYSIS OF EPHESUS STUDY

Basit Öğe Kaydı
dc.contributor.authorBasaran, O.
dc.contributor.authorDogan, V.
dc.contributor.authorMert, G. O.
dc.contributor.authorMert, K. U.
dc.contributor.authorOzlek, B.
dc.contributor.authorCelik, O.
dc.contributor.authorOzlek, E.
dc.contributor.authorCil, C.
dc.contributor.authorBekar, L.
dc.contributor.authorAktas, M.
dc.contributor.authorResulzade, M.
dc.contributor.authorKalcik, M.
dc.contributor.authorAksan, G.
dc.contributor.authorCinier, G.
dc.contributor.authorAkay, K.
dc.contributor.authorSenol, U.
dc.contributor.authorDemir, V.
dc.contributor.authorInci, S.
dc.contributor.authorBiteker, M.
dc.contributor.authorKayikciolu, M.
dc.date.accessioned2019-10-27T09:42:09Z
dc.date.available2019-10-27T09:42:09Z
dc.date.issued2019
dc.departmentEge Üniversitesien_US
dc.description87th Congress of the European-Atherosclerosis-Society (EAS) -- MAY 26-29, 2019 -- Maastricht, NETHERLANDSen_US
dc.description.sponsorshipEuropean Atherosclerosis Socen_US
dc.identifier.doi10.1016/j.atherosclerosis.2019.06.618
dc.identifier.endpageE203en_US
dc.identifier.issn0021-9150
dc.identifier.issn1879-1484
dc.identifier.startpageE203en_US
dc.identifier.urihttps://doi.org/10.1016/j.atherosclerosis.2019.06.618
dc.identifier.urihttps://hdl.handle.net/11454/28721
dc.identifier.volume287en_US
dc.identifier.wosWOS:000482110800616en_US
dc.identifier.wosqualityQ1en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.language.isoenen_US
dc.publisherElsevier Ireland Ltden_US
dc.relation.ispartofAtherosclerosisen_US
dc.relation.publicationcategoryKonferans Öğesi - Uluslararası - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.titleLIPID LOWERING THERAPY USE IN SECONDARY PREVENTION: AN ANALYSIS OF EPHESUS STUDYen_US
dc.typeConference Objecten_US

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu